Probing the Impact of Added Al(OTf) 3 on DalPhos/Nickel‐Catalyzed N ‐Arylations of Amides with (Hetero)aryl Chlorides
European Journal of Organic Chemistry · 13.12.2023 · 26 (47)
DOI: 10.1002/ejoc.202301004 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Organic Chemistry, online erschienen am 15.11.2023. Verfasst von Michael J. Cotnam und 2 weiteren Autor:innen. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Dalhousie University.
Abstract (Originalsprache)
We disclose herein our study examining the potential activating effect of added aluminum triflate (5 mol %) on the (DalPhos)Ni(aryl)Cl (1 mol % Ni) catalyzed C−N cross‐coupling of primary amides with (hetero)aryl chlorides. In some instances, dramatically improved conversion to product was achieved by use of added aluminum triflate; with furfurylamine catalytic inhibition occurred. The reaction outcome appears to result from the interplay of DalPhos ligand and aryl group within the Ni pre‐catalyst, as well as the identity of the cross‐coupling partners.
Förderung
- Dalhousie University
Zitieren
APA
Cotnam, M. J., Martinek, N., & Stradiotto, M. (2023). Probing the Impact of Added Al(OTf) 3 on DalPhos/Nickel‐Catalyzed N ‐Arylations of Amides with (Hetero)aryl Chlorides. European Journal of Organic Chemistry, 26(47). https://doi.org/10.1002/ejoc.202301004
Vancouver
Cotnam MJ, Martinek N, Stradiotto M. Probing the Impact of Added Al(OTf) 3 on DalPhos/Nickel‐Catalyzed N ‐Arylations of Amides with (Hetero)aryl Chlorides. European Journal of Organic Chemistry. 2023;26(47). doi:10.1002/ejoc.202301004
BibTeX
@article{Cotnam2023,
author = {Cotnam, Michael J. and Martinek, Nicole and Stradiotto, Mark},
title = {Probing the Impact of Added Al(OTf) 3 on DalPhos/Nickel‐Catalyzed N ‐Arylations of Amides with (Hetero)aryl Chlorides},
journal = {European Journal of Organic Chemistry},
year = {2023},
volume = {26},
number = {47},
doi = {10.1002/ejoc.202301004}
}
EUVIMED